bullish
Shenzhen Hepalink (海瑞普) A+H: A Heparin-API King but Nothing Too Exciting
466 Views19 Feb 2020 16:25
Shenzhen Hepalink is seeking an up to USD 500 million in an A+H listing.The company is a dominant heparin supplier on a global scale but it is not...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
x